237 related articles for article (PubMed ID: 808963)
1. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
Beutler E; Kuhl W; Comings D
Am J Hum Genet; 1975 Sep; 27(5):628-38. PubMed ID: 808963
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Hex S, the major residual beta hexosaminidase activity in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
Ikonne JU; Rattazzi MC; Desnick RJ
Am J Hum Genet; 1975 Sep; 27(5):639-50. PubMed ID: 240271
[TBL] [Abstract][Full Text] [Related]
3. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.
Rattazzi MC; Brown JA; Davidson RG; Shows TB
Am J Hum Genet; 1976 Mar; 28(2):143-54. PubMed ID: 817596
[TBL] [Abstract][Full Text] [Related]
4. [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)].
Weil D; Van Cong N; Rebourcet R; Frézal J
Ann Genet; 1975 Sep; 18(3):163-8. PubMed ID: 810067
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
6. A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control.
Van Cong N; Weil D; Rebourcet R; Frézal J; Richard-Mollard AM
Ann Hum Genet; 1975 Jul; 39(1):111-23. PubMed ID: 810068
[TBL] [Abstract][Full Text] [Related]
7. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
Tsuji D
Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
[TBL] [Abstract][Full Text] [Related]
8. Western blotting analysis of the beta-hexosaminidase alpha- and beta-subunits in cultured fibroblasts from cases of various forms of GM2 gangliosidosis.
Utsumi K; Tsuji A; Kase R; Tanaka A; Tanaka T; Uyama E; Ozawa T; Sakuraba H; Komaba Y; Kawabe M; Iino Y; Katayama Y
Acta Neurol Scand; 2002 Jun; 105(6):427-30. PubMed ID: 12027830
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
10. Treatment of GM2 Gangliosidosis in Adult Sandhoff Mice Using an Intravenous Self-Complementary Hexosaminidase Vector.
Osmon KJ; Thompson P; Woodley E; Karumuthil-Melethil S; Heindel C; Keimel JG; Kaemmerer WF; Gray SJ; Walia JS
Curr Gene Ther; 2022; 22(3):262-276. PubMed ID: 34530708
[TBL] [Abstract][Full Text] [Related]
11. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene.
Wang P; Henthorn PS; Galban E; Lin G; Takedai T; Casal M
J Vet Intern Med; 2018 Jan; 32(1):340-347. PubMed ID: 29106755
[TBL] [Abstract][Full Text] [Related]
12. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid.
Yamato O; Satoh H; Matsuki N; Ono K; Yamasaki M; Maede Y
J Vet Diagn Invest; 2004 Jan; 16(1):39-44. PubMed ID: 14974845
[TBL] [Abstract][Full Text] [Related]
14. The biochemical genetics of the hexosaminidase system in man.
Beutler E
Am J Hum Genet; 1979 Mar; 31(2):95-105. PubMed ID: 377957
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset GM2 gangliosidosis diagnosed in a fetus.
Navon R; Sandbank U; Frisch A; Baram D; Adam A
Prenat Diagn; 1986; 6(3):169-76. PubMed ID: 2941730
[TBL] [Abstract][Full Text] [Related]
17. Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis.
Ornaghi F; Sala D; Tedeschi F; Maffia MC; Bazzucchi M; Morena F; Valsecchi M; Aureli M; Martino S; Gritti A
Neurobiol Dis; 2020 Feb; 134():104667. PubMed ID: 31682993
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis).
O'Dowd BF; Klavins MH; Willard HF; Gravel R; Lowden JA; Mahuran DJ
J Biol Chem; 1986 Sep; 261(27):12680-5. PubMed ID: 3017984
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant lysosomal β-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts.
Espejo-Mojica AJ; Rodríguez-López A; Li R; Zheng W; Alméciga-Díaz CJ; Dulcey-Sepúlveda C; Combariza G; Barrera LA
Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):885-895. PubMed ID: 33111489
[TBL] [Abstract][Full Text] [Related]
20. Antigenic homology of feline and human beta-hexosaminidase.
O'Neil DC; Bartholomew WR; Rattazzi MC
Biochim Biophys Acta; 1979 Sep; 580(1):1-9. PubMed ID: 94833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]